nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—CYP19A1—esophageal cancer	0.767	1	CbGaD
Levonorgestrel—Premenstrual tension—Capecitabine—esophageal cancer	0.00785	0.0843	CcSEcCtD
Levonorgestrel—Premenstrual syndrome—Capecitabine—esophageal cancer	0.00399	0.0428	CcSEcCtD
Levonorgestrel—Abdominal pain lower—Capecitabine—esophageal cancer	0.00206	0.0221	CcSEcCtD
Levonorgestrel—Varicose vein—Capecitabine—esophageal cancer	0.00176	0.0189	CcSEcCtD
Levonorgestrel—Pruritus genital—Capecitabine—esophageal cancer	0.00157	0.0168	CcSEcCtD
Levonorgestrel—Depressed mood—Capecitabine—esophageal cancer	0.00146	0.0157	CcSEcCtD
Levonorgestrel—Hirsutism—Capecitabine—esophageal cancer	0.00113	0.0121	CcSEcCtD
Levonorgestrel—Haemorrhoids—Capecitabine—esophageal cancer	0.00111	0.0119	CcSEcCtD
Levonorgestrel—Infection—Carboplatin—esophageal cancer	0.00107	0.0115	CcSEcCtD
Levonorgestrel—Ethinyl Estradiol—NR1I2—esophageal cancer	0.00107	0.131	CrCbGaD
Levonorgestrel—Nandrolone phenpropionate—CYP19A1—esophageal cancer	0.00106	0.13	CrCbGaD
Levonorgestrel—Hydrocortisone—ANXA1—esophageal cancer	0.00106	0.13	CrCbGaD
Levonorgestrel—Haematoma—Capecitabine—esophageal cancer	0.00104	0.0112	CcSEcCtD
Levonorgestrel—Tenderness—Cisplatin—esophageal cancer	0.00102	0.0109	CcSEcCtD
Levonorgestrel—Haemoglobin decreased—Capecitabine—esophageal cancer	0.000951	0.0102	CcSEcCtD
Levonorgestrel—Norgestimate—ABCC2—esophageal cancer	0.000931	0.114	CrCbGaD
Levonorgestrel—Pain—Carboplatin—esophageal cancer	0.000923	0.00991	CcSEcCtD
Levonorgestrel—Metrorrhagia—Capecitabine—esophageal cancer	0.000916	0.00984	CcSEcCtD
Levonorgestrel—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.000884	0.00949	CcSEcCtD
Levonorgestrel—Body temperature increased—Carboplatin—esophageal cancer	0.000853	0.00917	CcSEcCtD
Levonorgestrel—Fluid retention—Cisplatin—esophageal cancer	0.000843	0.00905	CcSEcCtD
Levonorgestrel—Otitis media—Capecitabine—esophageal cancer	0.00084	0.00903	CcSEcCtD
Levonorgestrel—Nandrolone decanoate—CYP19A1—esophageal cancer	0.000806	0.0988	CrCbGaD
Levonorgestrel—Polyp—Methotrexate—esophageal cancer	0.000801	0.0086	CcSEcCtD
Levonorgestrel—Vaginal discharge—Methotrexate—esophageal cancer	0.000801	0.0086	CcSEcCtD
Levonorgestrel—Folliculitis—Methotrexate—esophageal cancer	0.000775	0.00832	CcSEcCtD
Levonorgestrel—Contusion—Capecitabine—esophageal cancer	0.00075	0.00805	CcSEcCtD
Levonorgestrel—Protein urine present—Capecitabine—esophageal cancer	0.000734	0.00789	CcSEcCtD
Levonorgestrel—Cyst—Methotrexate—esophageal cancer	0.000729	0.00782	CcSEcCtD
Levonorgestrel—Herpes simplex—Capecitabine—esophageal cancer	0.00071	0.00762	CcSEcCtD
Levonorgestrel—Influenza like illness—Capecitabine—esophageal cancer	0.000635	0.00682	CcSEcCtD
Levonorgestrel—Urinary incontinence—Capecitabine—esophageal cancer	0.000632	0.00678	CcSEcCtD
Levonorgestrel—Candida infection—Capecitabine—esophageal cancer	0.000625	0.00671	CcSEcCtD
Levonorgestrel—Fluid retention—Capecitabine—esophageal cancer	0.000621	0.00667	CcSEcCtD
Levonorgestrel—Neoplasm—Capecitabine—esophageal cancer	0.000592	0.00635	CcSEcCtD
Levonorgestrel—Breast disorder—Cisplatin—esophageal cancer	0.000582	0.00625	CcSEcCtD
Levonorgestrel—Abnormal vision—Capecitabine—esophageal cancer	0.000571	0.00613	CcSEcCtD
Levonorgestrel—Protein urine present—Methotrexate—esophageal cancer	0.000547	0.00587	CcSEcCtD
Levonorgestrel—Sweating increased—Cisplatin—esophageal cancer	0.000542	0.00583	CcSEcCtD
Levonorgestrel—Vascular purpura—Capecitabine—esophageal cancer	0.000531	0.0057	CcSEcCtD
Levonorgestrel—Herpes simplex—Methotrexate—esophageal cancer	0.000528	0.00568	CcSEcCtD
Levonorgestrel—Libido decreased—Capecitabine—esophageal cancer	0.000512	0.0055	CcSEcCtD
Levonorgestrel—Increased appetite—Capecitabine—esophageal cancer	0.000505	0.00543	CcSEcCtD
Levonorgestrel—Purpura—Capecitabine—esophageal cancer	0.000493	0.00529	CcSEcCtD
Levonorgestrel—Danazol—CYP19A1—esophageal cancer	0.000488	0.0599	CrCbGaD
Levonorgestrel—Ethinyl Estradiol—ABCC2—esophageal cancer	0.00048	0.0589	CrCbGaD
Levonorgestrel—Cystitis noninfective—Methotrexate—esophageal cancer	0.000476	0.00511	CcSEcCtD
Levonorgestrel—Pain in extremity—Capecitabine—esophageal cancer	0.000475	0.0051	CcSEcCtD
Levonorgestrel—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000471	0.00506	CcSEcCtD
Levonorgestrel—Cystitis—Methotrexate—esophageal cancer	0.00047	0.00505	CcSEcCtD
Levonorgestrel—Migraine—Capecitabine—esophageal cancer	0.000467	0.00502	CcSEcCtD
Levonorgestrel—Vaginal infection—Methotrexate—esophageal cancer	0.00046	0.00494	CcSEcCtD
Levonorgestrel—Mood swings—Capecitabine—esophageal cancer	0.00045	0.00483	CcSEcCtD
Levonorgestrel—Bladder pain—Methotrexate—esophageal cancer	0.00044	0.00473	CcSEcCtD
Levonorgestrel—Neoplasm—Methotrexate—esophageal cancer	0.00044	0.00473	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Cisplatin—esophageal cancer	0.00044	0.00473	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Cisplatin—esophageal cancer	0.000438	0.0047	CcSEcCtD
Levonorgestrel—Urethral disorder—Cisplatin—esophageal cancer	0.000437	0.00469	CcSEcCtD
Levonorgestrel—Dry skin—Capecitabine—esophageal cancer	0.000435	0.00468	CcSEcCtD
Levonorgestrel—Visual impairment—Cisplatin—esophageal cancer	0.00043	0.00461	CcSEcCtD
Levonorgestrel—Breast disorder—Capecitabine—esophageal cancer	0.000429	0.00461	CcSEcCtD
Levonorgestrel—Eye disorder—Cisplatin—esophageal cancer	0.000417	0.00447	CcSEcCtD
Levonorgestrel—Cardiac disorder—Cisplatin—esophageal cancer	0.000414	0.00444	CcSEcCtD
Levonorgestrel—Abdominal distension—Capecitabine—esophageal cancer	0.000413	0.00444	CcSEcCtD
Levonorgestrel—Methyltestosterone—CYP19A1—esophageal cancer	0.000413	0.0506	CrCbGaD
Levonorgestrel—Asthma—Capecitabine—esophageal cancer	0.00041	0.00441	CcSEcCtD
Levonorgestrel—Influenza—Capecitabine—esophageal cancer	0.00041	0.00441	CcSEcCtD
Levonorgestrel—Immune system disorder—Cisplatin—esophageal cancer	0.000403	0.00432	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Cisplatin—esophageal cancer	0.000402	0.00431	CcSEcCtD
Levonorgestrel—Sweating increased—Capecitabine—esophageal cancer	0.0004	0.00429	CcSEcCtD
Levonorgestrel—Arrhythmia—Cisplatin—esophageal cancer	0.000398	0.00428	CcSEcCtD
Levonorgestrel—Bronchitis—Capecitabine—esophageal cancer	0.000395	0.00424	CcSEcCtD
Levonorgestrel—Alopecia—Cisplatin—esophageal cancer	0.000394	0.00423	CcSEcCtD
Levonorgestrel—Erythema—Cisplatin—esophageal cancer	0.000388	0.00417	CcSEcCtD
Levonorgestrel—Malnutrition—Cisplatin—esophageal cancer	0.000388	0.00417	CcSEcCtD
Levonorgestrel—Dysuria—Capecitabine—esophageal cancer	0.000384	0.00412	CcSEcCtD
Levonorgestrel—Flatulence—Cisplatin—esophageal cancer	0.000382	0.00411	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000381	0.0041	CcSEcCtD
Levonorgestrel—Weight increased—Capecitabine—esophageal cancer	0.000374	0.00401	CcSEcCtD
Levonorgestrel—Muscle spasms—Cisplatin—esophageal cancer	0.000373	0.00401	CcSEcCtD
Levonorgestrel—Weight decreased—Capecitabine—esophageal cancer	0.000371	0.00399	CcSEcCtD
Levonorgestrel—Pneumonia—Capecitabine—esophageal cancer	0.000368	0.00395	CcSEcCtD
Levonorgestrel—Infestation NOS—Capecitabine—esophageal cancer	0.000366	0.00393	CcSEcCtD
Levonorgestrel—Infestation—Capecitabine—esophageal cancer	0.000366	0.00393	CcSEcCtD
Levonorgestrel—Depression—Capecitabine—esophageal cancer	0.000365	0.00392	CcSEcCtD
Levonorgestrel—Anaemia—Cisplatin—esophageal cancer	0.000359	0.00385	CcSEcCtD
Levonorgestrel—Urinary tract infection—Capecitabine—esophageal cancer	0.000356	0.00382	CcSEcCtD
Levonorgestrel—Progesterone—CYP1B1—esophageal cancer	0.000345	0.0423	CrCbGaD
Levonorgestrel—Mood swings—Methotrexate—esophageal cancer	0.000335	0.0036	CcSEcCtD
Levonorgestrel—Myalgia—Cisplatin—esophageal cancer	0.00033	0.00355	CcSEcCtD
Levonorgestrel—Haemoglobin—Capecitabine—esophageal cancer	0.00033	0.00355	CcSEcCtD
Levonorgestrel—Rhinitis—Capecitabine—esophageal cancer	0.000329	0.00354	CcSEcCtD
Levonorgestrel—Anxiety—Cisplatin—esophageal cancer	0.000329	0.00354	CcSEcCtD
Levonorgestrel—Haemorrhage—Capecitabine—esophageal cancer	0.000329	0.00353	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000328	0.00352	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Capecitabine—esophageal cancer	0.000327	0.00351	CcSEcCtD
Levonorgestrel—Discomfort—Cisplatin—esophageal cancer	0.000326	0.0035	CcSEcCtD
Levonorgestrel—Testosterone—CYP1B1—esophageal cancer	0.000326	0.04	CrCbGaD
Levonorgestrel—Pharyngitis—Capecitabine—esophageal cancer	0.000326	0.0035	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Capecitabine—esophageal cancer	0.000324	0.00348	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Capecitabine—esophageal cancer	0.000323	0.00347	CcSEcCtD
Levonorgestrel—Urethral disorder—Capecitabine—esophageal cancer	0.000322	0.00346	CcSEcCtD
Levonorgestrel—Breast disorder—Methotrexate—esophageal cancer	0.000319	0.00343	CcSEcCtD
Levonorgestrel—Oedema—Cisplatin—esophageal cancer	0.000317	0.0034	CcSEcCtD
Levonorgestrel—Visual impairment—Capecitabine—esophageal cancer	0.000317	0.0034	CcSEcCtD
Levonorgestrel—Infection—Cisplatin—esophageal cancer	0.000315	0.00338	CcSEcCtD
Levonorgestrel—Erythema multiforme—Capecitabine—esophageal cancer	0.000311	0.00334	CcSEcCtD
Levonorgestrel—Nervous system disorder—Cisplatin—esophageal cancer	0.000311	0.00334	CcSEcCtD
Levonorgestrel—Skin disorder—Cisplatin—esophageal cancer	0.000308	0.0033	CcSEcCtD
Levonorgestrel—Eye disorder—Capecitabine—esophageal cancer	0.000307	0.0033	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Cisplatin—esophageal cancer	0.000306	0.00329	CcSEcCtD
Levonorgestrel—Asthma—Methotrexate—esophageal cancer	0.000306	0.00328	CcSEcCtD
Levonorgestrel—Cardiac disorder—Capecitabine—esophageal cancer	0.000305	0.00327	CcSEcCtD
Levonorgestrel—Anorexia—Cisplatin—esophageal cancer	0.000302	0.00324	CcSEcCtD
Levonorgestrel—Immune system disorder—Capecitabine—esophageal cancer	0.000297	0.00319	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Capecitabine—esophageal cancer	0.000296	0.00318	CcSEcCtD
Levonorgestrel—Arrhythmia—Capecitabine—esophageal cancer	0.000293	0.00315	CcSEcCtD
Levonorgestrel—Alopecia—Capecitabine—esophageal cancer	0.00029	0.00312	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000288	0.0031	CcSEcCtD
Levonorgestrel—Mental disorder—Capecitabine—esophageal cancer	0.000288	0.00309	CcSEcCtD
Levonorgestrel—Malnutrition—Capecitabine—esophageal cancer	0.000286	0.00307	CcSEcCtD
Levonorgestrel—Erythema—Capecitabine—esophageal cancer	0.000286	0.00307	CcSEcCtD
Levonorgestrel—Dysuria—Methotrexate—esophageal cancer	0.000286	0.00307	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000284	0.00305	CcSEcCtD
Levonorgestrel—Dyspnoea—Cisplatin—esophageal cancer	0.000282	0.00303	CcSEcCtD
Levonorgestrel—Flatulence—Capecitabine—esophageal cancer	0.000282	0.00303	CcSEcCtD
Levonorgestrel—SHBG—neck—esophageal cancer	0.000281	0.123	CbGeAlD
Levonorgestrel—Back pain—Capecitabine—esophageal cancer	0.000277	0.00297	CcSEcCtD
Levonorgestrel—Decreased appetite—Cisplatin—esophageal cancer	0.000275	0.00296	CcSEcCtD
Levonorgestrel—Muscle spasms—Capecitabine—esophageal cancer	0.000275	0.00295	CcSEcCtD
Levonorgestrel—Pneumonia—Methotrexate—esophageal cancer	0.000274	0.00294	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000273	0.00294	CcSEcCtD
Levonorgestrel—Infestation—Methotrexate—esophageal cancer	0.000272	0.00293	CcSEcCtD
Levonorgestrel—Infestation NOS—Methotrexate—esophageal cancer	0.000272	0.00293	CcSEcCtD
Levonorgestrel—Depression—Methotrexate—esophageal cancer	0.000272	0.00292	CcSEcCtD
Levonorgestrel—Pain—Cisplatin—esophageal cancer	0.000271	0.00291	CcSEcCtD
Levonorgestrel—Progesterone—CYP2A6—esophageal cancer	0.000266	0.0326	CrCbGaD
Levonorgestrel—Anaemia—Capecitabine—esophageal cancer	0.000264	0.00284	CcSEcCtD
Levonorgestrel—Vertigo—Capecitabine—esophageal cancer	0.000257	0.00276	CcSEcCtD
Levonorgestrel—Syncope—Capecitabine—esophageal cancer	0.000256	0.00275	CcSEcCtD
Levonorgestrel—Palpitations—Capecitabine—esophageal cancer	0.000253	0.00271	CcSEcCtD
Levonorgestrel—Loss of consciousness—Capecitabine—esophageal cancer	0.000251	0.0027	CcSEcCtD
Levonorgestrel—Body temperature increased—Cisplatin—esophageal cancer	0.00025	0.00269	CcSEcCtD
Levonorgestrel—Cough—Capecitabine—esophageal cancer	0.00025	0.00268	CcSEcCtD
Levonorgestrel—Hypertension—Capecitabine—esophageal cancer	0.000247	0.00265	CcSEcCtD
Levonorgestrel—Haemoglobin—Methotrexate—esophageal cancer	0.000246	0.00264	CcSEcCtD
Levonorgestrel—Haemorrhage—Methotrexate—esophageal cancer	0.000245	0.00263	CcSEcCtD
Levonorgestrel—Chest pain—Capecitabine—esophageal cancer	0.000243	0.00262	CcSEcCtD
Levonorgestrel—Myalgia—Capecitabine—esophageal cancer	0.000243	0.00262	CcSEcCtD
Levonorgestrel—Pharyngitis—Methotrexate—esophageal cancer	0.000243	0.00261	CcSEcCtD
Levonorgestrel—Anxiety—Capecitabine—esophageal cancer	0.000243	0.00261	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000242	0.0026	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Methotrexate—esophageal cancer	0.000242	0.00259	CcSEcCtD
Levonorgestrel—Discomfort—Capecitabine—esophageal cancer	0.000241	0.00258	CcSEcCtD
Levonorgestrel—Urethral disorder—Methotrexate—esophageal cancer	0.00024	0.00257	CcSEcCtD
Levonorgestrel—Testosterone—CYP19A1—esophageal cancer	0.000239	0.0294	CrCbGaD
Levonorgestrel—Visual impairment—Methotrexate—esophageal cancer	0.000236	0.00253	CcSEcCtD
Levonorgestrel—Oedema—Capecitabine—esophageal cancer	0.000233	0.00251	CcSEcCtD
Levonorgestrel—Hypersensitivity—Cisplatin—esophageal cancer	0.000233	0.00251	CcSEcCtD
Levonorgestrel—Infection—Capecitabine—esophageal cancer	0.000232	0.00249	CcSEcCtD
Levonorgestrel—Erythema multiforme—Methotrexate—esophageal cancer	0.000231	0.00248	CcSEcCtD
Levonorgestrel—Shock—Capecitabine—esophageal cancer	0.00023	0.00247	CcSEcCtD
Levonorgestrel—Nervous system disorder—Capecitabine—esophageal cancer	0.000229	0.00246	CcSEcCtD
Levonorgestrel—Eye disorder—Methotrexate—esophageal cancer	0.000229	0.00245	CcSEcCtD
Levonorgestrel—Asthenia—Cisplatin—esophageal cancer	0.000227	0.00244	CcSEcCtD
Levonorgestrel—Cardiac disorder—Methotrexate—esophageal cancer	0.000227	0.00244	CcSEcCtD
Levonorgestrel—Skin disorder—Capecitabine—esophageal cancer	0.000227	0.00243	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Capecitabine—esophageal cancer	0.000226	0.00242	CcSEcCtD
Levonorgestrel—Anorexia—Capecitabine—esophageal cancer	0.000222	0.00239	CcSEcCtD
Levonorgestrel—Immune system disorder—Methotrexate—esophageal cancer	0.000221	0.00237	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Methotrexate—esophageal cancer	0.00022	0.00237	CcSEcCtD
Levonorgestrel—Diarrhoea—Cisplatin—esophageal cancer	0.000217	0.00233	CcSEcCtD
Levonorgestrel—Alopecia—Methotrexate—esophageal cancer	0.000216	0.00232	CcSEcCtD
Levonorgestrel—Mental disorder—Methotrexate—esophageal cancer	0.000214	0.0023	CcSEcCtD
Levonorgestrel—Malnutrition—Methotrexate—esophageal cancer	0.000213	0.00229	CcSEcCtD
Levonorgestrel—Erythema—Methotrexate—esophageal cancer	0.000213	0.00229	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000213	0.00228	CcSEcCtD
Levonorgestrel—Insomnia—Capecitabine—esophageal cancer	0.000211	0.00227	CcSEcCtD
Levonorgestrel—Dyspnoea—Capecitabine—esophageal cancer	0.000208	0.00223	CcSEcCtD
Levonorgestrel—Back pain—Methotrexate—esophageal cancer	0.000206	0.00221	CcSEcCtD
Levonorgestrel—Dyspepsia—Capecitabine—esophageal cancer	0.000205	0.00221	CcSEcCtD
Levonorgestrel—Decreased appetite—Capecitabine—esophageal cancer	0.000203	0.00218	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000202	0.00216	CcSEcCtD
Levonorgestrel—Vomiting—Cisplatin—esophageal cancer	0.000201	0.00216	CcSEcCtD
Levonorgestrel—Fatigue—Capecitabine—esophageal cancer	0.000201	0.00216	CcSEcCtD
Levonorgestrel—Rash—Cisplatin—esophageal cancer	0.0002	0.00214	CcSEcCtD
Levonorgestrel—Pain—Capecitabine—esophageal cancer	0.0002	0.00214	CcSEcCtD
Levonorgestrel—Constipation—Capecitabine—esophageal cancer	0.0002	0.00214	CcSEcCtD
Levonorgestrel—Dermatitis—Cisplatin—esophageal cancer	0.000199	0.00214	CcSEcCtD
Levonorgestrel—ESR1—neck—esophageal cancer	0.000198	0.0863	CbGeAlD
Levonorgestrel—Anaemia—Methotrexate—esophageal cancer	0.000197	0.00211	CcSEcCtD
Levonorgestrel—Vertigo—Methotrexate—esophageal cancer	0.000191	0.00205	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000191	0.00205	CcSEcCtD
Levonorgestrel—Nausea—Cisplatin—esophageal cancer	0.000188	0.00202	CcSEcCtD
Levonorgestrel—Cough—Methotrexate—esophageal cancer	0.000186	0.002	CcSEcCtD
Levonorgestrel—Urticaria—Capecitabine—esophageal cancer	0.000185	0.00199	CcSEcCtD
Levonorgestrel—Abdominal pain—Capecitabine—esophageal cancer	0.000185	0.00198	CcSEcCtD
Levonorgestrel—Body temperature increased—Capecitabine—esophageal cancer	0.000185	0.00198	CcSEcCtD
Levonorgestrel—Myalgia—Methotrexate—esophageal cancer	0.000181	0.00195	CcSEcCtD
Levonorgestrel—Chest pain—Methotrexate—esophageal cancer	0.000181	0.00195	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00018	0.00193	CcSEcCtD
Levonorgestrel—Discomfort—Methotrexate—esophageal cancer	0.000179	0.00192	CcSEcCtD
Levonorgestrel—Ethinyl Estradiol—ABCB1—esophageal cancer	0.000177	0.0217	CrCbGaD
Levonorgestrel—Infection—Methotrexate—esophageal cancer	0.000173	0.00185	CcSEcCtD
Levonorgestrel—PGR—epithelium—esophageal cancer	0.000172	0.0751	CbGeAlD
Levonorgestrel—Hypersensitivity—Capecitabine—esophageal cancer	0.000172	0.00185	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methotrexate—esophageal cancer	0.00017	0.00183	CcSEcCtD
Levonorgestrel—Norethindrone—ABCB1—esophageal cancer	0.00017	0.0208	CrCbGaD
Levonorgestrel—Skin disorder—Methotrexate—esophageal cancer	0.000169	0.00181	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methotrexate—esophageal cancer	0.000168	0.0018	CcSEcCtD
Levonorgestrel—Asthenia—Capecitabine—esophageal cancer	0.000167	0.0018	CcSEcCtD
Levonorgestrel—PGR—smooth muscle tissue—esophageal cancer	0.000166	0.0724	CbGeAlD
Levonorgestrel—Anorexia—Methotrexate—esophageal cancer	0.000166	0.00178	CcSEcCtD
Levonorgestrel—Pruritus—Capecitabine—esophageal cancer	0.000165	0.00177	CcSEcCtD
Levonorgestrel—Diarrhoea—Capecitabine—esophageal cancer	0.00016	0.00172	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000158	0.0017	CcSEcCtD
Levonorgestrel—Insomnia—Methotrexate—esophageal cancer	0.000157	0.00169	CcSEcCtD
Levonorgestrel—Dyspnoea—Methotrexate—esophageal cancer	0.000155	0.00166	CcSEcCtD
Levonorgestrel—Somnolence—Methotrexate—esophageal cancer	0.000154	0.00166	CcSEcCtD
Levonorgestrel—Dizziness—Capecitabine—esophageal cancer	0.000154	0.00166	CcSEcCtD
Levonorgestrel—Dyspepsia—Methotrexate—esophageal cancer	0.000153	0.00164	CcSEcCtD
Levonorgestrel—Decreased appetite—Methotrexate—esophageal cancer	0.000151	0.00162	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00015	0.00161	CcSEcCtD
Levonorgestrel—Fatigue—Methotrexate—esophageal cancer	0.00015	0.00161	CcSEcCtD
Levonorgestrel—Pain—Methotrexate—esophageal cancer	0.000149	0.0016	CcSEcCtD
Levonorgestrel—Vomiting—Capecitabine—esophageal cancer	0.000148	0.00159	CcSEcCtD
Levonorgestrel—Rash—Capecitabine—esophageal cancer	0.000147	0.00158	CcSEcCtD
Levonorgestrel—Dermatitis—Capecitabine—esophageal cancer	0.000147	0.00158	CcSEcCtD
Levonorgestrel—Headache—Capecitabine—esophageal cancer	0.000146	0.00157	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000142	0.00153	CcSEcCtD
Levonorgestrel—Nausea—Capecitabine—esophageal cancer	0.000139	0.00149	CcSEcCtD
Levonorgestrel—Urticaria—Methotrexate—esophageal cancer	0.000138	0.00148	CcSEcCtD
Levonorgestrel—Abdominal pain—Methotrexate—esophageal cancer	0.000137	0.00148	CcSEcCtD
Levonorgestrel—Body temperature increased—Methotrexate—esophageal cancer	0.000137	0.00148	CcSEcCtD
Levonorgestrel—AR—epithelium—esophageal cancer	0.000137	0.0598	CbGeAlD
Levonorgestrel—AR—bronchus—esophageal cancer	0.000135	0.0589	CbGeAlD
Levonorgestrel—ESR1—epithelium—esophageal cancer	0.000135	0.0588	CbGeAlD
Levonorgestrel—AR—smooth muscle tissue—esophageal cancer	0.000132	0.0577	CbGeAlD
Levonorgestrel—ESR1—smooth muscle tissue—esophageal cancer	0.00013	0.0566	CbGeAlD
Levonorgestrel—Hypersensitivity—Methotrexate—esophageal cancer	0.000128	0.00137	CcSEcCtD
Levonorgestrel—Asthenia—Methotrexate—esophageal cancer	0.000125	0.00134	CcSEcCtD
Levonorgestrel—Pruritus—Methotrexate—esophageal cancer	0.000123	0.00132	CcSEcCtD
Levonorgestrel—Hydrocortisone—ABCB1—esophageal cancer	0.000122	0.0149	CrCbGaD
Levonorgestrel—Diarrhoea—Methotrexate—esophageal cancer	0.000119	0.00128	CcSEcCtD
Levonorgestrel—Dizziness—Methotrexate—esophageal cancer	0.000115	0.00123	CcSEcCtD
Levonorgestrel—Vomiting—Methotrexate—esophageal cancer	0.00011	0.00119	CcSEcCtD
Levonorgestrel—Rash—Methotrexate—esophageal cancer	0.00011	0.00118	CcSEcCtD
Levonorgestrel—Dermatitis—Methotrexate—esophageal cancer	0.000109	0.00118	CcSEcCtD
Levonorgestrel—PGR—lung—esophageal cancer	0.000109	0.0477	CbGeAlD
Levonorgestrel—Headache—Methotrexate—esophageal cancer	0.000109	0.00117	CcSEcCtD
Levonorgestrel—AR—digestive system—esophageal cancer	0.000104	0.0455	CbGeAlD
Levonorgestrel—Nausea—Methotrexate—esophageal cancer	0.000103	0.00111	CcSEcCtD
Levonorgestrel—ESR1—digestive system—esophageal cancer	0.000102	0.0447	CbGeAlD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	9.93e-05	0.00077	CbGpPWpGaD
Levonorgestrel—Progesterone—ABCB1—esophageal cancer	9.9e-05	0.0121	CrCbGaD
Levonorgestrel—CYP19A1—Metabolism—BLVRB—esophageal cancer	9.89e-05	0.000767	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SLC52A3—esophageal cancer	9.89e-05	0.000767	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—HIST1H2BM—esophageal cancer	9.81e-05	0.000761	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	9.81e-05	0.000761	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—WWOX—esophageal cancer	9.81e-05	0.000761	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GDI2—esophageal cancer	9.77e-05	0.000758	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—TP53—esophageal cancer	9.65e-05	0.000748	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	9.65e-05	0.000748	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.6e-05	0.000744	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—EP300—esophageal cancer	9.47e-05	0.000734	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	9.43e-05	0.000731	CbGpPWpGaD
Levonorgestrel—Testosterone—ABCB1—esophageal cancer	9.36e-05	0.0115	CrCbGaD
Levonorgestrel—PGR—Signaling Pathways—FKBP1A—esophageal cancer	9.33e-05	0.000724	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	9.25e-05	0.000717	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	9.23e-05	0.000716	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—EP300—esophageal cancer	9.22e-05	0.000715	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—PIK3CA—esophageal cancer	9.14e-05	0.000709	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	9.12e-05	0.000707	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—WIF1—esophageal cancer	9.12e-05	0.000707	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—ERBB2—esophageal cancer	8.92e-05	0.000692	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	8.91e-05	0.000691	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	8.87e-05	0.000688	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SMG6—esophageal cancer	8.86e-05	0.000687	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	8.85e-05	0.000686	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	8.84e-05	0.000686	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NOTCH3—esophageal cancer	8.76e-05	0.000679	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NR1I2—esophageal cancer	8.71e-05	0.000676	CbGpPWpGaD
Levonorgestrel—AR—lung—esophageal cancer	8.71e-05	0.038	CbGeAlD
Levonorgestrel—AR—Generic Transcription Pathway—SMAD4—esophageal cancer	8.56e-05	0.000664	CbGpPWpGaD
Levonorgestrel—ESR1—lung—esophageal cancer	8.55e-05	0.0373	CbGeAlD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	8.52e-05	0.000661	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CREBBP—esophageal cancer	8.49e-05	0.000658	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CSNK1A1—esophageal cancer	8.42e-05	0.000653	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CA1—esophageal cancer	8.41e-05	0.000652	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SLC10A2—esophageal cancer	8.41e-05	0.000652	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NOTCH1—esophageal cancer	8.28e-05	0.000642	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—MYC—esophageal cancer	8.25e-05	0.00064	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	8.24e-05	0.000639	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	8.15e-05	0.000631	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	8.07e-05	0.000626	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	7.92e-05	0.000614	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PFN1—esophageal cancer	7.87e-05	0.00061	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NOTCH2—esophageal cancer	7.85e-05	0.000609	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	7.84e-05	0.000608	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CA2—esophageal cancer	7.69e-05	0.000596	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	7.65e-05	0.000593	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—CDKN1A—esophageal cancer	7.62e-05	0.000591	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PSME2—esophageal cancer	7.61e-05	0.00059	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PSME1—esophageal cancer	7.61e-05	0.00059	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—NOS3—esophageal cancer	7.6e-05	0.000589	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	7.54e-05	0.000585	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	7.52e-05	0.000583	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—CREBBP—esophageal cancer	7.51e-05	0.000582	CbGpPWpGaD
Levonorgestrel—PGR—lymph node—esophageal cancer	7.48e-05	0.0326	CbGeAlD
Levonorgestrel—AR—Gene Expression—HIST1H2BM—esophageal cancer	7.48e-05	0.00058	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	7.43e-05	0.000576	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	7.29e-05	0.000565	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	7.27e-05	0.000563	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NOTCH3—esophageal cancer	7.18e-05	0.000557	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	7.17e-05	0.000556	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PLCE1—esophageal cancer	7.15e-05	0.000554	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ADH7—esophageal cancer	7.15e-05	0.000554	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	7.1e-05	0.00055	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	7.09e-05	0.00055	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ELMO1—esophageal cancer	7.07e-05	0.000548	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KMT2D—esophageal cancer	7.06e-05	0.000548	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PTGS2—esophageal cancer	6.95e-05	0.000539	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	6.94e-05	0.000538	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKAP13—esophageal cancer	6.91e-05	0.000536	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	6.84e-05	0.00053	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—TP53—esophageal cancer	6.77e-05	0.000525	CbGpPWpGaD
Levonorgestrel—CYP19A1—lymph node—esophageal cancer	6.73e-05	0.0294	CbGeAlD
Levonorgestrel—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	6.72e-05	0.000521	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NR1I2—esophageal cancer	6.71e-05	0.00052	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	6.69e-05	0.000518	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—SMAD4—esophageal cancer	6.59e-05	0.000511	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	6.56e-05	0.000509	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NOTCH2—esophageal cancer	6.44e-05	0.000499	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HIST1H2BM—esophageal cancer	6.38e-05	0.000495	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	6.35e-05	0.000493	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	6.35e-05	0.000492	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PDE4D—esophageal cancer	6.32e-05	0.00049	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NOTCH1—esophageal cancer	6.31e-05	0.000489	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADCYAP1—esophageal cancer	6.3e-05	0.000488	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ADH1B—esophageal cancer	6.27e-05	0.000486	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	6.22e-05	0.000482	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—EGFR—esophageal cancer	6.18e-05	0.000479	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	6.04e-05	0.000468	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GNG7—esophageal cancer	6.01e-05	0.000466	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TYMP—esophageal cancer	5.99e-05	0.000465	CbGpPWpGaD
Levonorgestrel—AR—lymph node—esophageal cancer	5.96e-05	0.026	CbGeAlD
Levonorgestrel—ESR1—lymph node—esophageal cancer	5.85e-05	0.0255	CbGeAlD
Levonorgestrel—CYP19A1—Metabolism—CYP26A1—esophageal cancer	5.83e-05	0.000452	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	5.83e-05	0.000452	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	5.8e-05	0.00045	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PSME1—esophageal cancer	5.8e-05	0.00045	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PSME2—esophageal cancer	5.8e-05	0.00045	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—EP300—esophageal cancer	5.78e-05	0.000448	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—HIST1H2BM—esophageal cancer	5.76e-05	0.000446	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—WWOX—esophageal cancer	5.76e-05	0.000446	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—CREBBP—esophageal cancer	5.72e-05	0.000444	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	5.71e-05	0.000443	CbGpPWpGaD
Levonorgestrel—CYP3A4—digestive system—esophageal cancer	5.71e-05	0.0249	CbGeAlD
Levonorgestrel—CYP19A1—Metabolism—ALOX15—esophageal cancer	5.68e-05	0.00044	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	5.64e-05	0.000437	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—XIAP—esophageal cancer	5.64e-05	0.000437	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	5.61e-05	0.000435	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FKBP1A—esophageal cancer	5.48e-05	0.000425	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NOTCH3—esophageal cancer	5.47e-05	0.000424	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TPI1—esophageal cancer	5.42e-05	0.00042	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTO1—esophageal cancer	5.42e-05	0.00042	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—SMAD4—esophageal cancer	5.41e-05	0.000419	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	5.37e-05	0.000417	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—PIK3CA—esophageal cancer	5.37e-05	0.000416	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—WIF1—esophageal cancer	5.35e-05	0.000415	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CTNNA1—esophageal cancer	5.33e-05	0.000413	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	5.3e-05	0.000411	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL2—esophageal cancer	5.3e-05	0.000411	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	5.27e-05	0.000408	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	5.22e-05	0.000405	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALDOB—esophageal cancer	5.2e-05	0.000403	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	5.15e-05	0.000399	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GAPDH—esophageal cancer	5e-05	0.000388	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CRABP1—esophageal cancer	4.96e-05	0.000384	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PSME1—esophageal cancer	4.95e-05	0.000384	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PSME2—esophageal cancer	4.95e-05	0.000384	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CSNK1A1—esophageal cancer	4.94e-05	0.000383	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ANXA1—esophageal cancer	4.93e-05	0.000382	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NOTCH2—esophageal cancer	4.91e-05	0.000381	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NOTCH1—esophageal cancer	4.86e-05	0.000377	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SST—esophageal cancer	4.79e-05	0.000372	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GNG7—esophageal cancer	4.72e-05	0.000366	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GHRL—esophageal cancer	4.67e-05	0.000362	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH3—esophageal cancer	4.67e-05	0.000362	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PFN1—esophageal cancer	4.62e-05	0.000358	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FBXW7—esophageal cancer	4.59e-05	0.000356	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.47e-05	0.000347	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PSME2—esophageal cancer	4.47e-05	0.000346	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PSME1—esophageal cancer	4.47e-05	0.000346	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—MYC—esophageal cancer	4.46e-05	0.000346	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALDH2—esophageal cancer	4.42e-05	0.000343	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—CREBBP—esophageal cancer	4.41e-05	0.000342	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.32e-05	0.000335	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PIK3CA—esophageal cancer	4.28e-05	0.000331	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH3—esophageal cancer	4.22e-05	0.000327	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTT1—esophageal cancer	4.2e-05	0.000326	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH2—esophageal cancer	4.19e-05	0.000325	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2A6—esophageal cancer	4.15e-05	0.000322	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ELMO1—esophageal cancer	4.15e-05	0.000322	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.14e-05	0.000321	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SMAD4—esophageal cancer	4.12e-05	0.00032	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKAP13—esophageal cancer	4.06e-05	0.000315	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NOTCH1—esophageal cancer	3.99e-05	0.000309	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS1—esophageal cancer	3.94e-05	0.000305	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ENO1—esophageal cancer	3.94e-05	0.000305	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PSME1—esophageal cancer	3.88e-05	0.000301	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PSME2—esophageal cancer	3.88e-05	0.000301	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH2—esophageal cancer	3.78e-05	0.000293	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HIST1H2BM—esophageal cancer	3.74e-05	0.00029	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFBR2—esophageal cancer	3.72e-05	0.000288	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PDE4D—esophageal cancer	3.71e-05	0.000288	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—CREBBP—esophageal cancer	3.62e-05	0.00028	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GNG7—esophageal cancer	3.53e-05	0.000274	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SMAD4—esophageal cancer	3.52e-05	0.000273	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—MYC—esophageal cancer	3.4e-05	0.000263	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.39e-05	0.000263	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP1B1—esophageal cancer	3.35e-05	0.00026	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—XIAP—esophageal cancer	3.31e-05	0.000256	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SMAD4—esophageal cancer	3.17e-05	0.000246	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CTNNA1—esophageal cancer	3.13e-05	0.000242	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL2—esophageal cancer	3.11e-05	0.000241	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NOTCH1—esophageal cancer	3.04e-05	0.000236	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PSME1—esophageal cancer	2.91e-05	0.000225	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PSME2—esophageal cancer	2.91e-05	0.000225	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ANXA1—esophageal cancer	2.89e-05	0.000224	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.89e-05	0.000224	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.89e-05	0.000224	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HIF1A—esophageal cancer	2.88e-05	0.000223	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMOX1—esophageal cancer	2.87e-05	0.000223	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.82e-05	0.000219	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SST—esophageal cancer	2.81e-05	0.000218	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ABCB1—esophageal cancer	2.76e-05	0.000214	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—CREBBP—esophageal cancer	2.75e-05	0.000214	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KDR—esophageal cancer	2.75e-05	0.000213	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GHRL—esophageal cancer	2.74e-05	0.000212	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH3—esophageal cancer	2.74e-05	0.000212	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FBXW7—esophageal cancer	2.7e-05	0.000209	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—MYC—esophageal cancer	2.62e-05	0.000203	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH1—esophageal cancer	2.59e-05	0.000201	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH2—esophageal cancer	2.46e-05	0.000191	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.45e-05	0.00019	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CA1—esophageal cancer	2.45e-05	0.00019	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CREBBP—esophageal cancer	2.35e-05	0.000182	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH1—esophageal cancer	2.34e-05	0.000181	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CA2—esophageal cancer	2.25e-05	0.000174	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFBR2—esophageal cancer	2.18e-05	0.000169	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MYC—esophageal cancer	2.15e-05	0.000166	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—CREBBP—esophageal cancer	2.12e-05	0.000165	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOS3—esophageal cancer	2.1e-05	0.000163	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ADH7—esophageal cancer	2.09e-05	0.000162	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.09e-05	0.000162	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.08e-05	0.000162	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SMAD4—esophageal cancer	2.06e-05	0.00016	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ERBB2—esophageal cancer	1.97e-05	0.000153	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CREBBP—esophageal cancer	1.84e-05	0.000143	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.83e-05	0.000142	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TYMP—esophageal cancer	1.75e-05	0.000136	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCND1—esophageal cancer	1.74e-05	0.000135	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.7e-05	0.000132	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HIF1A—esophageal cancer	1.69e-05	0.000131	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN1A—esophageal cancer	1.68e-05	0.00013	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.66e-05	0.000129	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NOS3—esophageal cancer	1.65e-05	0.000128	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MYC—esophageal cancer	1.63e-05	0.000127	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KDR—esophageal cancer	1.62e-05	0.000125	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EP300—esophageal cancer	1.6e-05	0.000124	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TPI1—esophageal cancer	1.58e-05	0.000123	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.58e-05	0.000123	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH1—esophageal cancer	1.52e-05	0.000118	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.52e-05	0.000118	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—esophageal cancer	1.51e-05	0.000117	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.46e-05	0.000113	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.45e-05	0.000112	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MYC—esophageal cancer	1.4e-05	0.000108	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CREBBP—esophageal cancer	1.38e-05	0.000107	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GNG7—esophageal cancer	1.38e-05	0.000107	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EGFR—esophageal cancer	1.36e-05	0.000106	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.29e-05	0.0001	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MYC—esophageal cancer	1.26e-05	9.76e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—EP300—esophageal cancer	1.26e-05	9.73e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOS3—esophageal cancer	1.24e-05	9.58e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.23e-05	9.51e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.21e-05	9.4e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CA—esophageal cancer	1.18e-05	9.18e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ERBB2—esophageal cancer	1.16e-05	8.96e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.15e-05	8.91e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ENO1—esophageal cancer	1.15e-05	8.91e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—esophageal cancer	1.15e-05	8.88e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PSME2—esophageal cancer	1.13e-05	8.78e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PSME1—esophageal cancer	1.13e-05	8.78e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCND1—esophageal cancer	1.02e-05	7.91e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN1A—esophageal cancer	9.87e-06	7.66e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.77e-06	7.58e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EP300—esophageal cancer	9.4e-06	7.28e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CA—esophageal cancer	9.29e-06	7.2e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP19A1—esophageal cancer	9.19e-06	7.12e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.38e-06	6.5e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MYC—esophageal cancer	8.19e-06	6.35e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCB1—esophageal cancer	8.05e-06	6.24e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EGFR—esophageal cancer	8.01e-06	6.21e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CA—esophageal cancer	6.95e-06	5.39e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—esophageal cancer	6.72e-06	5.21e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.38e-06	4.17e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NOS3—esophageal cancer	4.82e-06	3.73e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.4e-06	3.41e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—EP300—esophageal cancer	3.66e-06	2.84e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.71e-06	2.1e-05	CbGpPWpGaD
